These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1188483)

  • 1. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
    Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
    Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
    Russell A; Statter M; Shina A; Perlman M
    Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
    Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
    Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
    Mogoş T; Cheţa CP; Mincu IT
    Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical-genetic studies in maple syrup disease].
    Goedde HW; Blume KG
    Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature].
    Grossi-Bianchi ML; Gatti R; Marchi AG
    Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M aple syrup urine disease. A review with a report of an additional case.
    Schwartz JF; Kolendrianos ET
    Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-metabolic aspects of maple syrup urine disease and manifestation of some new trophometabolic relationships].
    Popa W; Apostolescu I; Popescu G
    Pediatria (Bucur); 1970; 19(1):51-6. PubMed ID: 5419930
    [No Abstract]   [Full Text] [Related]  

  • 11. Maple syrup urine disease metabolites studies in cerebellum cultures.
    Silberberg DH
    J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
    [No Abstract]   [Full Text] [Related]  

  • 12. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maple syrup urine disease. (Valine-leucine-uria)].
    Platt D; Beneke G; Peiffer J; Schmidt GW
    Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dietetics in hereditary enzyme deficiencies].
    Royer P
    Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674
    [No Abstract]   [Full Text] [Related]  

  • 16. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

  • 17. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapy of maple syrup urine disease.
    Snyderman SE
    Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme activity in classical and variant forms of maple syrup urine disease.
    Dancis J; Hutzler J; Snyderman SE; Cox RP
    J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.